CSF1R inhibitors pexidartinib and sotuletinib induce rapid glial ablation despite their limited brain penetrability
Olaf van Tellingen(Dutch Cancer Society), Laura E. Kuil(The Netherlands Cancer Institute), Sanne B. Schagen(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Artur M Burylo(The Netherlands Cancer Institute), Caroline van Heijningen(The Netherlands Cancer Institute), Efi Tsouri(The Netherlands Cancer Institute), Yoran M Leter(The Netherlands Cancer Institute), Zoey J Tolboom(The Netherlands Cancer Institute), Mark C. de Gooijer(Manchester Academic Health Science Centre)
Cited by 0
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768